🔎 Trials Near Me

መነሻ › የኤንዶሜትሪየም ካንሰር › አላባማ › Birmingham

በBirmingham፣ AL ለየኤንዶሜትሪየም ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች

ለየኤንዶሜትሪየም ካንሰር የሚደረጉ 16 ጥናቶች በBirmingham እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • University of Alabama at Birmingham Cancer Center, Birmingham
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ5 ኦክቶ 2026 · NCT07198074

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of Alabama at Birmingham Cancer Center, Birmingham
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT05564377

A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • GSK Investigational Site, Birmingham
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ2 ኦክቶ 2026 · NCT07286331

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital, Birmingham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06760819

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of Alabama at Birmingham Cancer Center, Birmingham
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT05112601

DESTINY-PANTUMOUR04

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Research Site, Birmingham
እድሜ ከ18 እስከ 130 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07124000

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of Alabama_6th Ave, Birmingham
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT03564340

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • University of Alabama at Birmingham, Birmingham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT05059444

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of Alabama Birmingham, Birmingham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ሴፕቴ 2026 · NCT06293898

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Children's Hospital of Alabama, Birmingham
12 Months – 30 Years · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT04851119

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of Alabama at Birmingham, Birmingham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ጁላይ 2026 · NCT04657068

The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
  • University of Alabama at Birmingham, Birmingham
እድሜ ከ18 እስከ 99 · ሴቶች · የተሻሻለው በ29 ጁላይ 2026 · NCT03538665

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of Alabama at Birmingham, Birmingham
  • University of Alabama at Birmingham, IDS Pharmacy, Birmingham
  • University of Alabama at Birmingham, Birmingham
  • እና 1 ተጨማሪ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁላይ 2026 · NCT05208762

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • 004, Birmingham
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ16 ጁላይ 2026 · NCT06906341

Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • O'Neal Comprehensive Cancer Center at UAB, Birmingham
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ15 ኤፕሪ 2026 · NCT05559879

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Massive Bio SYNERGY-AI site, Birmingham
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦክቶ 2025 · NCT03452774

በሌሎች ከተሞች ለየኤንዶሜትሪየም ካንሰር የሚደረጉ ጥናቶች

በBirmingham ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።